present paper reviews experimental results normal tissue tumour studies animals dose fraction dependence rbe normal tissues long recognised steeper increase rbe low doses late responding tissues compared acute reactions dose dependence tumours complex hypoxia reoxygenation differences repair capability high let damage comparison tumour normal tissue rbe values shows little experimental evidence therapeutic advantage clinically relevant doses particular rbe slow growing tumours lower faster growing mouse tumours reasons loss expected neutron benefits clinically relevant experiments discussed disappointing prospects neutrons contrasted current multifactorial approaches overcoming resistance conventional low let radiations including acceleration hyperfractionation types hypoxic cell radiosensitizers